00 1230 is the stock code of penghua pharmaceutical technology. On the one hand, the fund contract requires no less than 80% positions, on the other hand, the fund manager quickly opened positions and was unwilling to make timing, which lost the interests of investors.

According to the detailed data of fund net value, the fund started to open positions on June 5, with a unit net value of 1.05438+00 yuan; On June 12, the net value of the fund reached 1.0340 yuan, with a weekly increase of 3.3%; On June 19, the unit net value dropped sharply to 0.8690 yuan, with a weekly decline of 15.96%, and the Shanghai Composite Index fell by 13.32% in the same week.

Obviously, the fund opened its positions very quickly, reaching its peak before the plunge, so that the weekly net value fell more than the Shanghai Composite Index.

In the following weeks, the fund maintained a high positive correlation with the Shanghai Composite Index. In the week of July 3rd, the Shanghai Composite Index fell 12.07%, and Penghua Pharmaceutical Technology fell 15.73%. Obviously, the fund did not lighten its position and still maintained its top configuration.

Extended data:

Investment objective:

The Fund is a stock fund. Under the premise of effectively controlling risks, we will select high-quality listed companies in the pharmaceutical technology industry to strive for excess returns and long-term capital appreciation.

Investment scope:

The investment scope of the Fund is financial instruments with good liquidity, including domestic stocks (including small and medium-sized board, Growth Enterprise Market and other stocks listed with the approval of China Securities Regulatory Commission) and bonds (including government bonds, financial bonds, corporate bonds, central bank bills, medium-term notes, short-term financing bonds, subordinated bonds, convertible bonds, exchangeable bonds, private placement bond of small and medium-sized enterprises, etc.). ).

Money market instruments, warrants, asset-backed securities, stock index futures, laws and regulations or other financial instruments allowed by the China Securities Regulatory Commission for fund investment (subject to the relevant provisions of the China Securities Regulatory Commission).

If the future laws, regulations or regulatory agencies allow the Fund to invest in other varieties, the fund manager can include them in the investment scope after performing appropriate procedures.

The scale of People's Daily Online-Penghua Fund was "halved", and the graded fund suffered a big loss.